DESLORATADINE SOP

DESLORATADINE SOP

1.0 OBJECTIVE:

To lay down a procedure of analytical report for the active raw material of Desloratadine from the Pharmacopoeial specifications.

2.0 SCOPE:

This SOP shall be applicable in Q.C laboratory.

3.0 RESPONSIBILITY:

3.1 Q.C Analyst.

4.0 ACCOUNTABILITY:

4.1 Q.C Manager.

5.0 PROCEDURE:

5.1 Characters:

5.1.1 Appearance:

5.1.1.1 White or almost white powder.

5.1.2 Solubility:

5.1.2.1 Material and equipment:

5.1.2.1.1 Glassware (3 test tubes, spatula).

5.1.2.1.2 Heptane.

5.1.2.1.3 Ethanol (96%).

5.1.2.1.4 Purified water.

5.1.2.2 Sample:

5.1.2.2.1 Small quantity.

5.1.2.3 Method:

5.1.2.3.1 Take 3 test tubes and add small quantity of sample for testing solubility according to B.P specifications.

5.1.2.3.2 Add purified water in test tube 1, Ethanol (96%) in test tube 2 and heptane in test tube 3 in a small volume and observe the solubility of the sample.

5.1.2.4 Observations:

5.1.2.4.1 The sample in test tube 1 containing with purified water is very slightly soluble or practically insoluble.

5.1.2.4.2 The sample in test tube 2 containing with Ethanol (96%) is freely slightly soluble.

5.1.2.4.3 The sample in test tube 3 containing with heptane is slightly soluble or very slightly soluble.

5.2 Assay:

5.2.1 Apparatus:

5.2.1.1 HPLC apparatus.

5.2.1.2 Glassware (according to the requirement).

5.2.2 Material and reagents:

5.2.2.1 20.0mg of desloratadine CRS.

5.2.2.2 0.865g of sodium dodecyl sulfate R.

5.2.2.3 0.5ml of trifluoroacetic acid R.

5.2.2.4 Acetonitrile.

5.2.2.5 Purified water.

5.2.3 Sample:

5.2.3.1 20.0mg.

5.2.4 Test solution:

5.2.4.1 Take a beaker of 50.0ml and dissolve 20.0mg of the substance to be examined in the sufficient quantity of mobile phase.

5.2.4.2 Dilute it to 25.0ml with the mobile phase.

5.2.4.3 Take another beaker of 50.0ml and add above 5.0ml of solution in it.

5.2.4.4 Dilute it to 50.0ml with the mobile phase.

5.2.5 Reference solutions:

5.2.5.1 Reference solution (a):

5.2.5.1.1 Take a beaker of 50.0ml and dissolve 20.0mg of desloratadine CRS in the sufficient quantity of mobile phase.

5.2.5.1.2 Dilute it to 25.0ml with the mobile phase.

5.2.5.1.3 Take another beaker of 50.0ml and add above 5.0ml of solution in it.

5.2.5.1.4 Dilute it to 50.0ml with the mobile phase.

5.2.6 Column:

5.2.6.1 Size:

5.2.6.1.1 Length=0.25m,

5.2.6.1.2 θ=4.6mm.

5.2.6.2 Stationary phase:

5.2.6.2.1 End-capped octadecylsilyl silica gel for chromatography R (4μm).

5.2.6.3 Temperature:

5.2.6.3.1 35^oC.

5.2.7 Mobile phase:

5.2.7.1 Take a beaker of 1000.0ml and dissolve 0.865g of sodium dodecyl sulfate R in sufficient quantity of purified water.

5.2.7.2 Add 0.5ml of trifluoroacetic acid R. Mix it thoroughly.

5.2.7.3 Finally dilute it to 1000.0ml with purified water.

5.2.7.4 Take another beaker to prepare mobile phase with 57 volumes of this above solution and 43 volumes of acetonitrile R.

5.2.8 Flow rate:

5.2.8.1 1.0ml/min.

5.2.9 Detection:

5.2.9.1 Spectrophotometer at 280nm.

5.2.10 Injection:

5.2.10.1 100μL of the test solution and reference solution (a).

5.2.11 Run time:

5.2.11.1 2.5 times the retention time of desloratadine.

5.2.12 Relative retention time:

5.2.12.1 With reference to desloratadine (retention time=about 21 min).

5.2.13 System suitability: Reference solution (a):

5.2.13.1 Symmetry factor: 0.5 to 1.5 for the peak due to desloratadine.

5.2.14 Method of analysis:

5.2.14.1 Firstly prepare the test solution, reference solution and mobile phase according to the requirements.

5.2.14.2 The solutions must be free from solid particles.

5.2.14.3 Prepare the apparatus.

5.2.14.4 The mobile phase solvent mixtures must be de-aerated prior to use either by boiling or by applying a partial vacuum to the solvent reservoir.

5.2.14.5 Equilibrate the column with the prescribed mobile phase, flow rate and at temperature specified until a suitable baseline is achieved.

5.2.14.6 Test solution of the mixture to be separated is now introduced into the mobile phase with the help of an injector just before entering the separating column.

5.2.14.7 As the eluate leaves the column it enters a detector, where it is continuously monitored at the specified λ.

5.2.14.8 The electrical signal obtained from detector is amplified and routes to recorder which record the developed spectrum.

5.2.14.9 Calculate the percentage content of desloratadine (C₁₉H₁₉ClN₂) from the declared content of desloratadine CRS.

5.2.15 Observations:

5.2.15.1 98.0% to 102.0% (anhydrous substance).

6.0 REVISION LOG:

Revision No.	Effective Date	Reason
00		New SOP

7.0 REFERENCES:

7.1 The British Pharmacopoeia. Vol I., Official Monograph /Desloratadine: 2015, pp. 692-693.

8.0 ANNEXURES:

Annexure 1: Observations and calculations of HPLC method.

Annexure: 1

Observations and calculations of HPLC method

Analysis on HPLC

Instrument: ___________________ Date: _________________

Model: ___________________

Column size:	Length=
Column size:	θ=
Stationary phase:
Temperature:
Mobile phase:
Flow rate:
Injection size:
Detector:
Wavelength:	λ=

Sample solution: _______________________

Reference standard solution: ______________

Impurities: ____________________________

(calculate each component calculation separately)

OBSERVATIONS:

Attach Spectrum.

CALCULATIONS:

1. Retention time: n= no. of peak

Retention time of unretained peak (t_m)= _____________

No. of peaks	Retention time of peak of interest (t_r)_n	Height of peak of interest (h)_n	Width of peak of interest (w)_n	Area of peak of interest A=1/2(h x w)

2. Retention volume:

Flow rate= _______________ml/min.

No. of peaks	Retention time of peak of interest (t_r)_n	Retention volume = retention time x flow rate

3. Retention factor:

Retention time of unretained peak (t_m)= _____________

No. of peaks	Retention time of peak of interest (t_r)_n	Retention factor of a component k= (t_r-t_m)/t_m

4. Separation factor (α):

No. of peaks	Retention factor of a component (k_n)	Relative retention of two adjacent peaks α = k₂/k₁

5. Resolution:

Retention time of unretained peak (t_m)= _____________

No. of peaks	Retention time of peak of interest (t_r)_n	Width of peak of interest (w)_n	Resolution R_s = 2 (t_r2-t_r1) (w₁-w₂)

6. Efficiency:

No. of peaks or components	Retention time of peak of interest (t_r)_n	Width of peak of interest (w)_n	Efficiency (No. of theoretical plates) N= 16 (t_r/w)²

7. Height equivalent to a theoretical plate (HETP):

Length of column = ________________________

No. of peaks or components	No. of theoretical plates (N)	Height equivalent to a theoretical plate HETP = L/N

8. Symmetry factor (tailing factor):

No. of peaks or components	Distance from the peak max. to leading edge of the peak (f)	Width w		Symmetry factor
No. of peaks or components		At 5%	At 10%	A_s = w_5% 2f	A_s = w_10% 2f

9. Response factor & Relative response factor:

Conc. (mg/ml)= ___________________

No. of peak	Peak area	Response factor = (peak area/conc.)	Relative response factor = (response factor of impurity/response factor of API)

10. Relative standard deviation (%RSD):

Use formula of relative standard deviation where it is required i.e.,

11. Percentage of content:

Percentage content = (r_U/r_S) x (C_S/C_U) x 100.

r_U= peak response of substance from the sample solution.

r_S= peak response of substance from the standard solution.

C_S= concentration of substance in the standard solution (mg/mL).

C_U= concentration of substance in the sample solution (mg/mL).

RESULTS:

________________________________________________________________________________________________________________________________________________

9.0 ABBREVIATIONS:

Abbreviation	Expanded Form
SOP	Standard operating procedure
&	And
No.	Number
Ltd.	Limited
Q.C	Quality control
B.P	British pharmacopoeia
Vol	Volume
QCA	Quality control active ingredient
F	Format
μm	Micron/ micrometer
g/L	Gram per liter
ml	Milliliter
mg	Milligram
CRS	Chemical reference solution
m	Meter
θ	Theta
mm	Millimeter
^oC	Degree Celsius
ml/min	Milliliter per minute
nm	Nanometer
μL	Microliter
Min	Minute
λ	Lamda
%	Percentage